| Filter Options | ||||||
|---|---|---|---|---|---|---|
|
Public title |
Verify status |
Pay status |
||||
|
Study ailment |
Study type |
Study phase |
||||
|
Applicant |
Study leader |
Primary sponsor |
||||
|
Countries of recruitment and research settings |
|
|||||
| More Options | ||||||
| Reg No. in ChiCTR | Public title | Ailment | Type | Phase | Registration time | Viewed | Operation |
|---|---|---|---|---|---|---|---|
| 正在注册，尚未取得注册号 |
A Randomized Controlled Study of Different Dydrogesterone Regimens for the Treatment of Menorrhagia Peking University People's Hospital |
Menorrhagia |
Therapy Study |
Post-market |
2026-09-15 | 53 | Patient list |
| ITMCTR2026002439 |
Xiyuan Hospital, China Academy of Chinese Medical Sciences |
|
Therapy Study |
Premarket |
2026-08-18 | 220 | Patient list |
| ChiCTR2600119353 |
|
|
Prognostic Study |
Post-market |
2026-08-17 | 217 | Patient list |
| 0 |
Beijing United Family Hospital |
|
Therapy Study |
Post-market |
2026-08-05 | 223 | Patient list |
| 0 |
Beijing United Family Hospital |
|
Therapy Study |
Post-market |
2026-08-05 | 153 | Patient list |
| 0 |
Beijing United Family Hospital |
|
Therapy Study |
Post-market |
2026-08-05 | 121 | Patient list |
| 无 |
Peking University Third Hospital |
|
|
|
2026-07-13 | 335 | Patient list |
| NCT 07410039 |
Eculizumab Add-On Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study The First Medical Center of Chinese People's Liberation Army General Hospital |
|
Diagnostic Accuracy Test |
Post-market |
2026-06-26 | 387 | Patient list |
| 无 |
Efficacy Exploration and Safety Evaluation of an Emulsion Beijing Yiweishi Testing Technology Co., Ltd. |
|
Therapy Study |
Premarket |
2026-06-22 | 298 | Patient list |
| 284791 |
Peking University Cancer Hospital & Institute |
Cancer |
Diagnostic Accuracy Test |
|
2026-05-13 | 532 | Patient list |